SAB Biotherapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of SAB Biotherapeutics shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in SAB Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including SAB Biotherapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in SAB Biotherapeutics by Charles Schwab Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $11k | 16k | 0.69 |
2023-09-30 | $10k | 16k | 0.63 |
2023-06-30 | $14k | 16k | 0.83 |
2023-03-31 | $7.1k | 16k | 0.44 |
2022-12-31 | $9.6k | 16k | 0.59 |
2022-09-30 | $12k | 16k | 0.74 |
2022-06-30 | $24k | 16k | 1.48 |
2021-12-31 | $79k | 10k | 7.90 |